| Ident. | Authors (with country if any) | Title |
|---|
| 000110 |
P. Barone [Italie] | Treatment of depressive symptoms in Parkinson’s disease |
| 000152 |
F. Valldeoriola ; C. Coronell [Espagne] ; C. Pont ; M. T. Buongiorno ; A. Cámara ; C. Gaig ; Y. Compta | Socio‐demographic and clinical factors influencing the adherence to treatment in Parkinson’s disease: the ADHESON study |
| 000166 |
C. Becker [Suisse] ; G. P. Brobert ; S. Johansson [Suède] ; S. S. Jick [États-Unis] ; C. R. Meier [Suisse, États-Unis] | Risk of incident depression in patients with Parkinson disease in the UK |
| 000171 |
S. Giaquinto [Italie] ; L. Bruti [Italie] ; V. Dall'Armi [Italie] ; E. Palma [Italie] ; C. Spiridigliozzi [Italie] | Religious and spiritual beliefs in outpatients suffering from Parkinson Disease |
| 000177 |
M. Duleeka W. Knipe [Royaume-Uni] ; Mirdhu M. Wickremaratchi [Royaume-Uni] ; Emma Wyatt-Haines [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] | Quality of life in young‐ compared with late‐onset Parkinson's disease |
| 000202 |
Daniel Weintraub [États-Unis] ; David J. Burn [Royaume-Uni] | Parkinson's disease: The quintessential neuropsychiatric disorder |
| 000240 |
Vicki Shanker [États-Unis] ; Mark Groves [États-Unis] ; Gary Heiman [États-Unis] ; Christina Palmese [États-Unis] ; Rachel Saunders-Pullman [États-Unis] ; Laurie Ozelius [États-Unis] ; Deborah Raymond [États-Unis] ; Susan Bressman [États-Unis] | Mood and cognition in leucine‐rich repeat kinase 2 G2019S Parkinson's disease |
| 000242 |
Julius Huebl [Allemagne] ; Thomas Schoenecker [Allemagne] ; Sandy Siegert [Allemagne] ; Christof Brücke [Allemagne] ; Gerd-Helge Schneider [Allemagne] ; Andreas Kupsch [Allemagne] ; Kielan Yarrow [Royaume-Uni] ; Andrea A. Kühn [Allemagne] | Modulation of subthalamic alpha activity to emotional stimuli correlates with depressive symptoms in Parkinson's disease |
| 000322 |
A. Kummer [Brésil] ; P. Scalzo [Brésil] ; F. Cardoso [Brésil] ; A. L. Teixeira [Brésil] | Evaluation of fatigue in Parkinson’s disease using the Brazilian version of Parkinson’s Fatigue Scale |
| 000336 |
Stewart A. Factor [États-Unis] ; N. Kyle Steenland [États-Unis] ; Donald S. Higgins [États-Unis] ; Eric S. Molho [États-Unis] ; Denise M. Kay [États-Unis] ; Jennifer Montimurro [États-Unis] ; Ami R. Rosen [États-Unis] ; Cyrus P. Zabetian [États-Unis] ; Haydeh Payami [États-Unis] | Disease‐related and genetic correlates of psychotic symptoms in Parkinson's disease |
| 000343 |
Friederike Fritze [Norvège] ; Uwe Ehrt [Norvège] ; Hogne S Nnesyn [Norvège] ; Martin Kurz [Norvège] ; Tibor Hortobágyi [Royaume-Uni] ; Sabine Piepenstock Nore [Norvège] ; Clive Ballard [Royaume-Uni] ; Dag Aarsland [Norvège] | Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features |
| 000395 |
Francesca Assogna [Italie] ; Luca Cravello [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie] | Anhedonia in Parkinson's disease: A systematic review of the literature |
| 000490 |
David A. Gallagher [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Anette Schrag [Royaume-Uni] | What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? |
| 000520 |
Endre Pal [Hongrie] ; Ferenc Nagy [Hongrie] ; Zsuzsanna Aschermann [Hongrie] ; Eva Balazs [Hongrie] ; Norbert Kovacs [Hongrie] | The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double‐blind, placebo‐controlled study |
| 000627 |
Christopher G. Goetz [États-Unis] | New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease |
| 000717 |
P. O. Valko ; D. Waldvogel ; M. Weller ; C. L. Bassetti [Suisse] ; U. Held ; C. R. Baumann | Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment |
| 000727 |
Jens Clausen [Allemagne] | Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice |
| 000754 |
Katsuji Kobayashi [Japon] ; Hisashi Sumiya [Japon] ; Hiroyuki Nakano [Japon] ; Noriko Akiyama [Japon] ; Katsumi Urata [Japon] ; Yoshifumi Koshino [Japon] | Detection of Lewy body disease in patients with late‐onset depression, anxiety and psychotic disorder with myocardial meta‐iodobenzylguanidine scintigraphy |
| 000755 |
Arjan W. Braam [Pays-Bas] ; Aartjan T. F. Beekman [Pays-Bas] ; Michael E. Dewey [Royaume-Uni] ; Philippe A. E. G. Delespaul [Pays-Bas] ; Manfred Fichter [Allemagne] ; Antonio Lobo [Espagne] ; Hallgrímur Magnússon [Islande] ; Karine Pérès [France] ; Friedel M. Reischies [Allemagne] ; Marc Roelands [Belgique] ; Pedro Saz [Espagne] ; Robert A. Schoevers [Pays-Bas] ; Ingmar Skoog [Suède] ; John R. M. Copeland [Royaume-Uni] | Depression and parkinsonism in older Europeans: results from the EURODEP concerted action |
| 000814 |
Nadeeka N. W. Dissanayaka [Australie] ; Anna Sellbach [Australie] ; Sally Matheson [Australie] ; John D. O'Sullivan [Australie] ; Peter A. Silburn [Australie] ; Gerard J. Byrne [Australie] ; Rodney Marsh [Australie] ; George D. Mellick [Australie] | Anxiety disorders in Parkinson's disease: Prevalence and risk factors |
| 000844 |
Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Burn [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni] | A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy |
| 000914 |
James R. Williams [États-Unis] ; Laura Marsh [États-Unis] | Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment |
| 000933 |
Emily K. Plowman-Prine [États-Unis] ; Christine M. Sapienza [États-Unis] ; Michael S. Okun [États-Unis] ; Stephenie L. Pollock [États-Unis] ; Charles Jacobson [États-Unis] ; Sam S. Wu [États-Unis] ; John C. Rosenbek [États-Unis] | The relationship between quality of life and swallowing in Parkinson's disease |
| 000934 |
Matthew Menza [États-Unis] ; Roseanne Defronzo Dobkin [États-Unis] ; Humberto Marin [États-Unis] ; Margery H. Mark [États-Unis] ; Michael Gara [États-Unis] ; Steven Buyske [États-Unis] ; Karina Bienfait [États-Unis] ; Allison Dicke [États-Unis] | The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease |
| 000938 |
Bernard Ravina [États-Unis] ; Jordan Elm [États-Unis] ; Richard Camicioli [Canada] ; Peter G. Como [États-Unis] ; Laura Marsh [États-Unis] ; Joseph Jankovic [États-Unis] ; Daniel Weintraub [États-Unis] | The course of depressive symptoms in early Parkinson's disease |
| 000962 |
Susan H. Fox [Canada] ; Rosalind Chuang [Canada] ; Jonathan M. Brotchie [Canada] | Serotonin and Parkinson's disease: On movement, mood, and madness |
| 000979 |
Carmen Rodriguez-Blazquez [Espagne] ; Belen Frades-Payo [Espagne] ; Maria João Forjaz [Espagne] ; Jesus De Pedro-Cuesta [Espagne] ; Pablo Martinez-Martin [Espagne] | Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease |
| 000998 |
Paul Wicks [États-Unis] ; Graeme J. A. Macphee [Royaume-Uni] | Pathological gambling amongst Parkinson's disease and ALS patients in an online community (PatientsLikeMe.com) |
| 000A02 |
Arja Mainio [Finlande] ; Kaisa Karvonen [Finlande] ; Helin Hakko [Finlande] ; Terttu S Rkioja [Finlande] ; Pirkko R S Nen [Finlande] | Parkinson's disease and suicide: a profile of suicide victims with Parkinson's disease in a population‐based study during the years 1988–2002 in Northern Finland |
| 000A17 |
Dag Aarsland [Norvège, Royaume-Uni] ; Laura Marsh [États-Unis] ; Anette Schrag [Royaume-Uni] | Neuropsychiatric symptoms in Parkinson's disease |
| 000B25 |
Tultul Nayyar [États-Unis] ; Michael Bubser [États-Unis] ; Marcus C. Ferguson [États-Unis] ; M. Diana Neely [États-Unis] ; J. Shawn Goodwin [États-Unis] ; Thomas J. Montine [États-Unis] ; Ariel Y. Deutch [États-Unis] ; Twum A. Ansah [États-Unis] | Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation |
| 000B36 |
Nagaendran Kandiah [Singapour] ; Kaavya Narasimhalu [Singapour] ; Puay-Ngoh Lau [Singapour] ; Soo-Hoon Seah [Singapour] ; Wing Lok Au [Singapour] ; Louis C. S. Tan [Singapour] | Cognitive decline in early Parkinson's disease |
| 000C52 |
J. Koerts [Pays-Bas] ; K. L. Leenders [Pays-Bas] ; M. Koning [Pays-Bas] ; A. Bouma [Pays-Bas] ; M. Van Beilen [Pays-Bas] | The assessment of depression in Parkinson’s disease |
| 000C60 |
Sarra Nazem [États-Unis] ; Andrew D. Siderowf [États-Unis] ; John E. Duda [États-Unis] ; Gregory K. Brown [États-Unis] ; Tom Ten Have [États-Unis] ; Matthew B. Stern [États-Unis] ; Daniel Weintraub [États-Unis] | Suicidal and death ideation in Parkinson's disease |
| 000C95 |
L. Ishihara-Paul [Royaume-Uni] ; N. W. J. Wainwright [Royaume-Uni] ; K. Khaw [Royaume-Uni] ; R. N. Luben [Royaume-Uni] ; A. A. Welch [Royaume-Uni] ; N. E. Day [Royaume-Uni] ; C. Brayne [Royaume-Uni] ; P. G. Surtees [Royaume-Uni] | Prospective association between emotional health and clinical evidence of Parkinson’s disease |
| 000D27 |
Werner Poewe [Autriche] | Non‐motor symptoms in Parkinson’s disease |
| 000D28 |
Sean S. O'Sullivan [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; David A. Gallagher [Royaume-Uni] ; Luke A. Massey [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study |
| 000D44 |
J. Kulisevsky [Espagne] ; J. Pagonabarraga [Espagne] ; B. Pascual-Sedano [Espagne] ; A. Gironell [Espagne] ; C. García-Sánchez [Espagne] ; M. Martínez-Corral [Espagne] | Motor changes during sertraline treatment in depressed patients with Parkinson’s disease |
| 000E26 |
M. R. Lemke [Allemagne] | Depressive symptoms in Parkinson’s disease |
| 000E38 |
David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France] | Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study |
| 000E45 |
J. C. Möller [Allemagne] ; K. M. Eggert [Allemagne] ; M. Unger [Allemagne] ; P. Odin [Allemagne] ; K. R. Chaudhuri [Royaume-Uni] ; W. H. Oertel [Allemagne] | Clinical risk–benefit assessment of dopamine agonists |
| 000E46 |
Nathan Pankratz [États-Unis] ; Karen S. Marder [États-Unis] ; Cheryl A. Halter [États-Unis] ; Alice Rudolph [États-Unis] ; Cliff W. Shults [États-Unis] ; William C. Nichols [États-Unis] ; Tatiana Foroud [États-Unis] | Clinical correlates of depressive symptoms in familial Parkinson's disease |
| 000F48 |
Uwe Ehrt [Norvège] ; Kolbj Rn Br Nnick [Norvège] ; Peter Paul De Deyn [Belgique] ; Murat Emre [Turquie] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis] ; Dag Aarsland [Norvège] | Subthreshold depression in patients with Parkinson's disease and dementia––clinical and demographic correlates |
| 000F82 |
H. Ishii [Japon] ; K. Meguro [Japon] ; S. Yamaguchi [Japon] ; H. Ishikawa [Japon] ; A. Yamadori [Japon] | Prevalence and cognitive performances of vascular cognitive impairment no dementia in Japan: the Osaki–Tajiri Project |
| 001081 |
Peijun Chen [États-Unis] ; Helen C. Kales [États-Unis] ; Daniel Weintraub [États-Unis] ; Frederic C. Blow [États-Unis] ; Lan Jiang [États-Unis] ; Rosalinda V. Ignacio [États-Unis] ; Alan M. Mellow [États-Unis] | Depression in veterans with Parkinson's disease: frequency, co‐morbidity, and healthcare utilization |
| 001213 |
Angelo Antonini [Italie] ; Silvana Tesei [Italie] ; Anna Zecchinelli [Italie] ; Paolo Barone [Italie] ; Danilo De Gaspari [Italie] ; Margherita Canesi [Italie] ; Giorgio Sacilotto [Italie] ; Nicoletta Meucci [Italie] ; Claudio Mariani [Italie] ; Gianni Pezzoli [Italie] | Randomized study of sertraline and low‐dose amitriptyline in patients with Parkinson's disease and depression: Effect on quality of life |
| 001218 |
Laura Marsh [États-Unis] ; William M. Mcdonald [États-Unis] ; Jeffrey Cummings [États-Unis] ; Bernard Ravina [États-Unis] | Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group |
| 001324 |
Uwe Ehrt [Norvège] ; Kolbj Rn Br Nnick [Norvège] ; Albert F. G. Leentjens [Pays-Bas] ; Jan Petter Larsen [Norvège] ; Dag Aarsland [Norvège] | Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease |
| 001325 |
A. Lieberman [États-Unis] | Depression in Parkinson's disease – a review |
| 001329 |
Valerie Voon [Canada, États-Unis] ; Cynthia Kubu [États-Unis] ; Paul Krack [France] ; Jean-Luc Houeto [France] ; Alexander I. Tröster [États-Unis] | Deep brain stimulation: Neuropsychological and neuropsychiatric issues |
| 001366 |
L. Ishihara [Royaume-Uni] ; C. Brayne [Royaume-Uni] | A systematic review of depression and mental illness preceding Parkinson's disease |
| 001399 |
Hasmet A. Hanagasi ; Murat Emre [Turquie] | Treatment of behavioural symptoms and dementia in Parkinson's disease |
| 001469 |
J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Jürgen Köster [Allemagne] ; Gianni Pezzoli [Italie] ; Leandro Provinciali [Italie] | Long‐term efficacy and safety of pramipexole in advanced Parkinson's disease: Results from a European multicenter trial |
| 001501 |
Paulo S. Boggio [Brésil] ; Felipe Fregni [États-Unis] ; Felix Bermpohl [États-Unis] ; Carlos G. Mansur [Brésil] ; Moacyr Rosa [Brésil] ; Demetrio O. Rumi [Brésil] ; Egberto R. Barbosa [Brésil] ; Marina Odebrecht Rosa [Brésil] ; Alvaro Pascual-Leone [États-Unis] ; Sérgio Paulo Rigonatti [Brésil] ; Marco A. Marcolin [Brésil] ; Maria Teresa Araujo Silva [Brésil] | Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression |
| 001509 |
Philippe Remy [France] ; Miroslava Doder [France] ; Andrew Lees (neurologue) [Royaume-Uni, France] ; Nora Turjanski [France] ; David Brooks [France] | Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system |
| 001534 |
Daniel Weintraub [États-Unis] ; Knashawn H. Morales [États-Unis] ; Paul J. Moberg [États-Unis] ; Warren B. Bilker [États-Unis] ; Catherine Balderston [États-Unis] ; John E. Duda [États-Unis] ; Ira R. Katz [États-Unis] ; Matthew B. Stern [États-Unis] | Antidepressant studies in Parkinson's disease: A review and meta‐analysis |
| 001585 |
A. Nuti ; R. Ceravolo ; A. Piccinni [Italie] ; G. Dell'Agnello ; G. Bellini ; G. Gambaccini ; C. Rossi ; C. Logi ; L. Dell'Osso [Italie] ; U. Bonuccelli | Psychiatric comorbidity in a population of Parkinson's disease patients |
| 001790 |
J. Uekermann [Allemagne] ; I. Daum [Allemagne] ; S. Peters [Allemagne] ; B. Wiebel [Allemagne] ; H. Przuntek [Allemagne] ; T. Müller [Allemagne] | Depressed mood and executive dysfunction in early Parkinson's disease |
| 001792 |
Taresa Stefurak [Canada] ; David Mikulis [Canada] ; Helen Mayberg [Canada] ; Anthony E. Lang [Canada] ; Stephanie Hevenor [Canada] ; Peter Pahapill [États-Unis] ; Jean Saint-Cyr [Canada] ; Andres Lozano [Canada] | Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: A functional MRI case study |
| 001826 |
Svenja Happe ; Klaus Berger | The association between caregiver burden and sleep disturbances in partners of patients with Parkinson's disease |
| 001911 |
D. J. Burn [Royaume-Uni] | Depression in Parkinson's disease |
| 001913 |
A. F. G. Leentjens [Pays-Bas] ; F. R. J. Verhey [Pays-Bas] | Depression and Parkinson's disease: a conceptual challenge |
| 001933 |
David J. Burn [Royaume-Uni] | Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease |
| 001A16 |
S. Happe ; B. Schrödl ; M. Faltl [Autriche] ; C. Müller [Autriche] ; E. Auff [Autriche] ; J. Zeitlhofer | Sleep disorders and depression in patients with Parkinson's disease |
| 001B07 |
Saša R. Filipovi [Serbie] ; Nadežda Šterni [Serbie] ; Marina Svetel [Serbie] ; Nataša Dragaševi [Serbie] ; Dušica Le Ic [Serbie] ; Vladimir S. Kosti [Serbie] | Bereitschaftspotential in depressed and non‐depressed patients with Parkinson's disease |
| 001B61 |
Albert F. G. Leentjens [Pays-Bas] ; Frans R. J. Verhey [Pays-Bas] ; Richel Lousberg [Pays-Bas] ; Harro Spitsbergen [Pays-Bas] ; Frederik W. Wilmink [Pays-Bas] | The validity of the Hamilton and Montgomery‐Åsberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease |
| 001B85 |
Dag Aarsland ; Jan Petter Larsen ; Elise Tandberg ; Knut Laake [Norvège] | Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study |
| 001D97 |
Jeffrey L. Cummings [États-Unis] ; Donna L. Masterman [États-Unis] | Depression in patients with Parkinson's disease |
| 001E54 |
J. Mendlewicz [Belgique] | The broad spectrum of comorbid depression: implications for treatment |
| 002141 |
Hm Van Praag [Pays-Bas] | Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression. A psycho-biological hypothesis |
| 002291 |
Lawrence H. Price [États-Unis] ; Dennis D. Spencer [États-Unis] ; Kenneth L. Marek [États-Unis] ; Richard J. Robbins [États-Unis] ; Csaba Leranth [États-Unis] ; Anita Farhi [États-Unis] ; Frederick Naftolin [États-Unis] ; Robert H. Roth [États-Unis] ; Benjamin S. Bunney [États-Unis] ; Paul B. Hoffer [États-Unis] ; Robert Makuch [États-Unis] ; D. Eugene Redmond Jr. [États-Unis] | Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease |
| 002352 |
G. Mathé [France] | Can an adjuvant treatment or a pharmacologic prevention be common to several diseases? The case of those associated to neuromediator defects |
| 002A50 |
M. A. Mena [Espagne] ; E G. Aguado [Espagne] ; J. G. De Yebenes [Espagne] | Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method |
